- Home
- / OncoSec Medical
OncoSec Medical
Stock Price
$0
2023-08-25
Market Capitalization
$1.7 M
2023-08-25
OncoSec Medical Summary
Company Summary
- Overview
- OncoSec Medical is a biotechnology company that develops intratumoral immunotherapies. It offers TAVO (tavokinogene telseplasmid), which delivers DNA-based interleukin-12 (IL-12) into tumors using electroporation. The company is active in therapies for metastatic melanoma and triple-negative breast cancer.
- Type
- Public
- Status
- Closed
- Founded
- 2011
- HQ
- Rochelle Park, NJ, US | view all locations
- Website
- https://oncosec.com/
- Cybersecurity rating
Table of Contents
Key People
Herbert Kim Lyerly, Director
LocationsView all
2 locations detected
Rochelle Park, NJ HQ
United States
365 W Passaic St Suite 400
San Diego, CA
United States
3565 General Atomics Ct #100
OncoSec Medical Financials
Summary Financials
- Net income (Q2, 2023)
- ($6.9M)
- Cash (Q2, 2023)
- $3.7M
- EBIT (Q2, 2023)
- ($7.7M)
- Enterprise value
- $1.4M